Literature DB >> 6428921

Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure.

S E Lukas, R R Griffiths.   

Abstract

Baboons were exposed to diazepam via continuous injection at doses of 0.125-20.0 mg/kg per day intragastrically (i.g.) for 7 days or to 20 mg/kg per day, i.g. for 1 h or 1 to 35 days. After diazepam administration, Ro 15-1788, a benzodiazepine antagonist was given (5.0 mg/kg i.m.) and precipitated benzodiazepine withdrawal was evaluated by scoring individual signs. The severity of the withdrawal, as indicated by the number of the different signs as well as by frequency of individual signs, increased as the dose and duration of diazepam exposure were increased. Consistent elevations in diazepam withdrawal signs were evident after a dose as low as 0.25 mg/kg per day for 7 days and after administration of 20 mg/kg per day for as short as 3-7 days. Data also suggested that history of previous benzodiazepine exposure sensitized animals to subsequent development of physical dependence. Overall, this study suggests that benzodiazepines produce meaningful functional changes in the central nervous system after exposure to relatively low doses and after relatively short durations of exposure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428921     DOI: 10.1016/0014-2999(84)90218-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  21 in total

Review 1.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

2.  Precipitated withdrawal in squirrel monkeys after repeated daily oral administration of alprazolam, diazepam, flunitrazepam or oxazepam.

Authors:  J R Martin; J L Moreau; F Jenck
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

3.  Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons.

Authors:  Amy K Goodwin; Wolfgang Froestl; Elise M Weerts
Journal:  Psychopharmacology (Berl)       Date:  2005-03-01       Impact factor: 4.530

4.  Triazolam attenuates amphetamine but not morphine conditioned place preferences.

Authors:  H O Pettit; W R Batsell; K Mueller
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys.

Authors:  H Fukase; K Fukuzaki; T Koja; R Nagata; S E Lukas
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

6.  Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil.

Authors:  W Löscher; D Hönack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

7.  Oral self-administration of triazolam, diazepam and ethanol in the baboon: drug reinforcement and benzodiazepine physical dependence.

Authors:  N A Ator; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 8.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

9.  Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure.

Authors:  Miriam Z Mintzer; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2004-09-25       Impact factor: 4.530

10.  Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation.

Authors:  Bradford D Fischer; Laura P Teixeira; Michael L van Linn; Ojas A Namjoshi; James M Cook; James K Rowlett
Journal:  Psychopharmacology (Berl)       Date:  2013-01-26       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.